Estrogen receptor messenger RNA splice variants are not involved in antiestrogen resistance in sublines of MCF-7 human breast cancer cells

Cancer Research

Volumn 57, Issue 4, 1997, Pages 585-589

  Madsen, Mogens W ^a   Reiter, Birgit E ^a   Larsen, Søren S ^a   Briand, Per ^a   Lykkesfeldt, Anne E ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; DRUG EFFICACY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; RECEPTOR DENSITY; RNA SPLICING; TISSUE DISTRIBUTION;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GENETIC VECTORS; HUMANS; POLYUNSATURATED ALKAMIDES; RECEPTORS, ESTROGEN; RNA SPLICING; RNA, MESSENGER; RNA, NEOPLASM; TAMOXIFEN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031051458     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Howell, A., DeFriend, D., Robertson, J., Blamey, R., and Walton, P. Response to a specific antiestrogen (ICI 182,780) in tamoxifen-resistant breast cancer. Lancet, 345: 29-30, 1995.
2. Lykkesfeldt, A. E., Larsen, S. S., and Briand, P. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment. Int. J. Cancer, 61: 529-534, 1995.
3. Katzenellenbogen, B. S. Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. J. Natl. Cancer Inst., 83: 1434-1435, 1991.
4. Johnston, S. R. D., Saccanni-Jotti, G., Smith, I. E., Salter, J., Newby, J., Coppen, M., Ebbs, S. R., and Dowsett, M. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer Cancer Res., 55: 3331-3338, 1995.
5. Pfeffer, U., Fecarotta, E., and Vidali, G. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res., 55: 2158-2165, 1995.
6. Wang, Y., and Miksicek, R. J. Identification of a dominant negative form of the human estrogen receptor Mol. Endocrinol., 5: 1707-1715, 1991.
7. Koehorst, S. G. A., Cox, J. J., Donker, G. H. Lopes da Silva, S., Burbach, J. P. H., Thijssen, J. H. H., and Blankenstein, M. A. Functional analysis of an alternative spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue. Mol. Cell. Endocrinol., 101: 237-245, 1994.
8. Fuqua, S. A. W., Fitzgerald, S. D., Chamness, G. C., Tandon, A. K., McDonell, D. P., Nawaz, Z., O'Malley, B. W., and McGuire, W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res., 51: 105-109, 1991.
9. R-I compared to the parental MCF-7 cell line. Mol. Cell. Endocrinol., 109: 197-207, 1995.
10. Fuqua, S. A. W., and Wolf, D. M. Molecular aspects of estrogen receptor variants in breast cancer Breast Cancer Res. Treat., 35: 233-241, 1995.
11. Fuqua, S. A. W., Fitzgerald, S. D., Allred, D. C., Elledge, R. M., Nawaz, Z., McDonnell, D. P., O'Malley, B. W., Greene, G. L., and McGuire, W. L. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res., 52: 483-486, 1992.
12. Lykkesfeldt, A. E., and Briand, P. Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines. Br. J. Cancer, 53: 29-35, 1986.
13. Briand, P., Petersen, O. W., and van Deurs, B. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell. & Dev. Biol., 23: 181-188, 1987.
14. Briand, P., and Lykkesfeldt, A. E. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration. Cancer Res., 44: 1114-1119, 1984.
15. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J-M., Argos, P., and Chambon, P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (Lond.), 320: 134-139, 1986.
16. Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I., and Chambon, P. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J., 8: 1981-1986, 1989.
17. Castles, C. G., Klotz, D. M., Fuqua, S. A. W., and Hill, S. M. Coexpression of wild-type and variant oestrogen receptor mRNAs in a panel of human breast cell lines. Br. J. Cancer, 71: 874-980, 1995.
18. Daffada, A. A. I., Johnston, S. R. D., Smith, I. E., Deter, S., King, N., and Dowsett, M. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor pS2 status in human breast cancer. Cancer Res., 55: 288-293, 1995.
19. Dauvois, S., Danielian, P. S., White, R., and Parker, M. G. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc. Natl. Acad. Sci. USA, 89: 4037-4041, 1992.
20. Castles, C. G., Fuqua, S. A. W., Klotz, D. M., and Hill, S. M. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res., 53: 5934-5939, 1993.
21. Villa, E., Camellini, L., Dugani, A., Zucchi, F., Grottola, A., Merighi, A., Buttafoco, P., Losi, L., and Manenti, F. Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma. Cancer Res., 55: 498- 500, 1995.
22. Skipper, J. K., Young, L. J., Bergeron, J. M., Tetzlaff, M. T., Osborn, C. T., and Crews, D. Identification of an isoform of the estrogen receptor messenger RNA lacking exon four and present in the brain. Proc. Natl. Acad. Sci. USA, 90: 71727175, 1993.
23. Pfeffer, U., Fecarotta, E., Arena, G., Forlani, A., and Vidali, G. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines. J. Steroid Biochem. Mol. Biol., 56: 99-105, 1996.